NU SKIN ENTERPRISES, INC. (NUS)

↓ Download CSV

CIK 0001021561 · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

  • Sector Wholesale Trade
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, NU SKIN ENTERPRISES, INC. reported revenue of $1.49B, down 14.3% from the prior year. The company was profitable, with a net margin of 10.8% and a gross margin of 69.4%. It held $1.41B in total assets against $600.07M in total liabilities.

Key ratios (FY2025)

69.4%
Gross margin
4.4%
Operating margin
10.8%
Net margin
19.9%
Return on equity
-14.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.49B$1.73B$1.97B$2.23B$2.70B$2.58B$2.42B$2.68B$2.28B$2.21B
Cost of Revenue$453.76M$550.23M$611.85M$630.91M$675.22M$658.03M$581.42M$634.14M$502.08M$500.46M
Gross Profit$1.03B$1.18B$1.36B$1.59B$2.02B$1.92B$1.84B$2.04B$1.78B$1.71B
Operating Income$65.76M-$151.59M$48.27M$110.85M$233.99M$257.56M$267.43M$240.86M$274.48M$231.10M
Net Income$160.20M-$146.59M$8.60M$104.78M$147.27M$191.35M$173.55M$121.89M$129.44M$143.09M
EPS (Diluted)$3.18$-2.95$0.17$2.07$2.86$3.63$3.10$2.16$2.36$2.55
Total Assets$1.41B$1.47B$1.81B$1.82B$1.91B$1.96B$1.77B$1.69B$1.59B$1.47B
Total Liabilities$600.07M$817.46M$986.66M$923.67M$993.71M$1.06B$893.72M$912.58M$885.28M$809.98M
Shareholders' Equity$805.24M$651.46M$821.97M$897.30M$912.77M$894.27M$875.29M$781.87M$704.60M$664.07M
Cash & Equivalents$238.63M$186.88M$256.06M$264.73M$339.59M$402.68M$335.63M$386.91M$426.40M$357.25M
Operating Cash Flow$80.29M$111.74M$118.64M$108.06M$141.58M$379.14M$177.93M$202.74M$302.56M$275.26M
Capital Expenditures$34.28M$41.58M$58.49M$59.06M$68.61M$63.82M$66.07M$70.37M$60.16M$50.22M
Shares Outstanding50.30M49.66M49.86M50.52M51.43M52.77M55.93M56.48M54.85M56.10M